Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04762771 · ClinicalTrials.gov registry record · Phase 1
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
A Phase 1 study, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT04762771: Clinical Trial Phase 1 study, sponsored by Baptist Health South Florida.
NCT04762771 is a Phase 1 study that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04762771, a Phase 1 study, was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)
Primary Outcome
Composite of all-cause mortality
Interventions
- DRUG Colchicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2021-09-20 |
| Phase | Phase 1 |
Why NCT04762771 stopped before completion
NCT04762771 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Colchicine is the first listed.
NCT04762771 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04762771 about?
NCT04762771 is a clinical study titled "Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)". This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)
What is the current status of trial NCT04762771?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2020-12-23. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT04762771?
The interventions under investigation include: Colchicine (DRUG).
Who is sponsoring clinical trial NCT04762771?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04762771's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI